Skip to main content
. 2016 Dec 21;8(2):1983–1992. doi: 10.18632/oncotarget.14077

Table 1. Levels of cytokines (pg/mg) and ROS (/%) in SAMR1, SAMP8 and following SS31 treatment (mean ± SD).

Groups TNF-α* IL-1β** IL-2 IL-6* IL-10 ROS**
SAMR1 24.75±5.44 38.75±9.22 179.00±56.15 8.25±3.30 32.75±12.04 100.00±39.23
SAMP8 40.50±12.40& 57.50±3.42& 266.75±14.01 13.75±2.50& 37.25±5.68 294.83±92.91&
SS31 28.50±8.39 40.75±5.06# 233.74±74.91 10.10±3.92 37.50±12.92 208.78±56.64#

Overall analysis: * P < 0.05; ** P < 0.01

Posthoc analysis: & P < 0.05: SAMP8 vs. SAMR1 mice; #P < 0.05: SS31 vs. SAMP8 mice.